Overview
Camptodactyly syndrome, Guadalajara type 2 is an extremely rare genetic disorder characterized by a combination of camptodactyly (permanent flexion contractures of the fingers), distinctive facial features, and skeletal abnormalities. This condition was first described in patients from Guadalajara, Mexico, and is distinguished from Guadalajara type 1 by its specific constellation of clinical features. The syndrome affects multiple body systems. Key clinical features include camptodactyly, short stature, microcephaly (abnormally small head), intellectual disability, and characteristic craniofacial anomalies such as a flat face, small mouth (microstomia), and abnormalities of the ears. Skeletal manifestations may include abnormalities of the vertebrae, short neck, and other bone anomalies. Additional features can involve the musculoskeletal system with muscle hypoplasia or atrophy, as well as neck and spinal abnormalities. Due to the extreme rarity of this condition, there is no specific treatment available. Management is supportive and symptomatic, focusing on addressing individual clinical manifestations. This may include orthopedic interventions for skeletal abnormalities, physical and occupational therapy for hand function and motor development, and educational support for intellectual disability. Genetic counseling is recommended for affected families. The condition has been reported in very few families worldwide, making large-scale clinical studies challenging.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Camptodactyly syndrome, Guadalajara type 2.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Camptodactyly syndrome, Guadalajara type 2 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Camptodactyly syndrome, Guadalajara type 2.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Camptodactyly syndrome, Guadalajara type 2.
Community
No community posts yet. Be the first to share your experience with Camptodactyly syndrome, Guadalajara type 2.
Start the conversation →Latest news about Camptodactyly syndrome, Guadalajara type 2
No recent news articles for Camptodactyly syndrome, Guadalajara type 2.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Camptodactyly syndrome, Guadalajara type 2
What is Camptodactyly syndrome, Guadalajara type 2?
Camptodactyly syndrome, Guadalajara type 2 is an extremely rare genetic disorder characterized by a combination of camptodactyly (permanent flexion contractures of the fingers), distinctive facial features, and skeletal abnormalities. This condition was first described in patients from Guadalajara, Mexico, and is distinguished from Guadalajara type 1 by its specific constellation of clinical features. The syndrome affects multiple body systems. Key clinical features include camptodactyly, short stature, microcephaly (abnormally small head), intellectual disability, and characteristic craniofa
How is Camptodactyly syndrome, Guadalajara type 2 inherited?
Camptodactyly syndrome, Guadalajara type 2 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Camptodactyly syndrome, Guadalajara type 2 typically begin?
Typical onset of Camptodactyly syndrome, Guadalajara type 2 is neonatal. Age of onset can vary across affected individuals.